Found 6 matching trials
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
PHASE2MARIO-3 is a Phase 2 multi-arm combination cohort study designed to evaluat...
Location
Ironwood Cancer and Research Center
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
PHASE1This dose-escalation study will evaluate the safety, tolerability, pharmaco...
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
PHASE2The purpose of this study is to measure the effect of IPI-549 in combinatio...
Location
Parkview Physicians
IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
PHASE2The purpose of this study is to investigate how effective the study drug IP...
Location
UC San Diego Moores Cancer Center
Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
PHASE1This study is to evaluate the safety and preliminary efficacy of adding the...
Location
Brigham and Women's Hospital
A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies
PHASE1This is a Phase 1/1b, open-label, dose-escalation, and dose-expansion study...
Location
Scottsdale Healthcare Hospitals dba Honor Health Research Institute